According to Lyell Immunopharma's latest financial reports the company's current revenue (TTM ) is ₹5.35 Million. In 2023 the company made a revenue of ₹10.82 Million a decrease over the revenue in the year 2022 that were of ₹7.00 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.